Breaking News2 years ago
Targeted therapy momelotinib provides significant symptom and anemia improvements in patients with myelofibrosis
[ad_1] Newswise — Patients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anemia and spleen enlargement, when treated with the targeted therapy momelotinib, according...
